Women welcome Singapore's move to subsidise genetic testing for hereditary breast and ovarian cancer and cover preventive surgery. Read more at straitstimes.com. Read more at straitstimes.com.

GeneDx Holdings Corp. (NASDAQ:WGS) is one of the most promising stocks under $100 to buy. On March 10, GeneDx and Zevra Therapeutics (NASDAQ:ZVRA) announced a new partnership to launch a sponsored ...

In this episode of The OncoloGIST, breast cancer oncologist and clinical researcher Dr Paolo Tarantino of Dana-Farber Cancer Institute reflects on how antibody-drug conjugates (AD ...

A common oral bacterium tied to gum disease may help spark and fuel breast cancer, according to new research. Scientists discovered it can travel through the bloodstream to breast tissue, where it ...

Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.

This longtime UVA employee underwent three preventative surgeries at once to reduce her risk of breast and ovarian cancer linked to a BRCA1 mutation.

CNW/ - Seven early career scientists across Canada are launching new cancer research programs thanks to $3.5 million in funding through the Terry Fox ...

Myriad Genetics receives US FDA approval for MyChoice CDx test as companion diagnostic for Zejula for patients with ovarian cancer: Salt Lake City Thursday, March 19, 2026, 15:00 ...

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that the U.S. Food and Drug ...

A study highlights a gap in cancer prevention, showing men undergo genetic testing less often yet are more likely to carry high-risk cancer variants.

Last year, EastEnders legend Kara Tointon underwent a double mastectomy and had her fallopian tubes removed after discovering ...